Di Tian1, Khan Rizwan1, Yi Liu2, Lulu Kang2, Yanlin Yang2, Xiao Mao3, Li Shu4. 1. Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, 410008, Hunan, China. 2. Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China. 3. Department of Medical Genetics, Maternal and Child Health Hospital of Hunan province, Changsha, 410008, China. gbtechies@outlook.com. 4. Department of Medical Genetics, Maternal and Child Health Hospital of Hunan province, Changsha, 410008, China. shulibbm@163.com.
Abstract
BACKGROUND: Microtubule dynamics is crucial for neuronal function and survival. The disrupted function of microtubule dynamics would lead to neurodegenerative and neurodevelopmental disorders. Tubulin-specific chaperone D (TBCD) is one of five tubulin co-chaperones acted in assembly and disassembly dynamics of microtubule. The biallelic pathogenic variants of TBCD gene were reported to be associated with severe degenerative encephalopathy accompanied with seizures previously. RESULTS: Compound heterozygous variants were identified in three patients from three families. The in silico prediction software and ACMG standards and guidelines proved the pathogenicity of the TBCD pathogenic variants. The clinical features of the three patients presented with mild neurodevelopmental manifestations including autism spectrum disorder (ASD) and occasional generalized tonic-clonic seizures (GTCSs) responding well to antiepileptic drugs. CONCLUSION: Our research expanded the clinical spectrum of TBCD-related neurodevelopmental disease which contributed to understanding the genotype-phenotype correlations of the disease.
BACKGROUND: Microtubule dynamics is crucial for neuronal function and survival. The disrupted function of microtubule dynamics would lead to neurodegenerative and neurodevelopmental disorders. Tubulin-specific chaperone D (TBCD) is one of five tubulin co-chaperones acted in assembly and disassembly dynamics of microtubule. The biallelic pathogenic variants of TBCD gene were reported to be associated with severe degenerative encephalopathy accompanied with seizures previously. RESULTS: Compound heterozygous variants were identified in three patients from three families. The in silico prediction software and ACMG standards and guidelines proved the pathogenicity of the TBCD pathogenic variants. The clinical features of the three patients presented with mild neurodevelopmental manifestations including autism spectrum disorder (ASD) and occasional generalized tonic-clonic seizures (GTCSs) responding well to antiepileptic drugs. CONCLUSION: Our research expanded the clinical spectrum of TBCD-related neurodevelopmental disease which contributed to understanding the genotype-phenotype correlations of the disease.
Authors: Matthew J Maenner; Catherine E Rice; Carrie L Arneson; Christopher Cunniff; Laura A Schieve; Laura A Carpenter; Kim Van Naarden Braun; Russell S Kirby; Amanda V Bakian; Maureen S Durkin Journal: JAMA Psychiatry Date: 2014-03 Impact factor: 21.596
Authors: B Pode-Shakked; H Barash; L Ziv; K W Gripp; E Flex; O Barel; K S Carvalho; M Scavina; G Chillemi; M Niceta; E Eyal; N Kol; B Ben-Zeev; O Bar-Yosef; D Marek-Yagel; E Bertini; A L Duker; Y Anikster; M Tartaglia; A Raas-Rothschild Journal: Clin Genet Date: 2016-12-16 Impact factor: 4.438
Authors: Alex Bayés; Mark O Collins; Mike D R Croning; Louie N van de Lagemaat; Jyoti S Choudhary; Seth G N Grant Journal: PLoS One Date: 2012-10-05 Impact factor: 3.240
Authors: Joshi Stephen; Sheela Nampoothiri; K P Vinayan; Dhanya Yesodharan; Preetha Remesh; William A Gahl; May Christine V Malicdan Journal: BMC Med Genet Date: 2018-05-16 Impact factor: 2.103
Authors: Ana Heras-Molina; Yolanda Núñez; Rita Benítez; José Luis Pesántez-Pacheco; Consolación García-Contreras; Marta Vázquez-Gómez; Susana Astiz; Beatriz Isabel; Antonio González-Bulnes; Cristina Óvilo Journal: PLoS One Date: 2022-08-16 Impact factor: 3.752